Cargando…

Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry

The diagnosis of myelodysplastic syndromes (MDS) might be challenging and relies on the convergence of cytological, cytogenetic, and molecular factors. Multiparametric flow cytometry (MFC) helps diagnose MDS, especially when other features do not contribute to the decision-making process, but its us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clichet, Valentin, Lebon, Delphine, Chapuis, Nicolas, Zhu, Jaja, Bardet, Valérie, Marolleau, Jean-Pierre, Garçon, Loïc, Caulier, Alexis, Boyer, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2023
Materias:	Article - Myelodysplastic Syndromes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483367/ https://www.ncbi.nlm.nih.gov/pubmed/36924240 http://dx.doi.org/10.3324/haematol.2022.282370

Ejemplares similares

High transferrin saturation predicts inferior clinical outcomes in patients with myelodysplastic syndromes
por: Teichman, Jennifer, et al.
Publicado: (2022)

Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes
por: Fischer, Melissa A., et al.
Publicado: (2022)

CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine
por: Karantanos, Theodoros, et al.
Publicado: (2022)

Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation
por: Muto, Tomoya, et al.
Publicado: (2023)

Role of iron chelation in improving survival: An integral part of current therapy for myelodysplastic syndromes
por: Taran, Sachi Jain, et al.
Publicado: (2015)

Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer
por: Petrone, Giulia, et al.
Publicado: (2022)

Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasms
por: Badar, Talha, et al.
Publicado: (2023)

Immunogenicity of Covid-19 Vaccination in Subjects with Myelodysplastic Syndromes
por: Vidler, Jennifer, et al.
Publicado: (2021)

Myelodysplastic Syndromes (MDS) & COVID-19: Clinical Experience from the US Epicenter of the Pandemic
por: Feld, Jonathan, et al.
Publicado: (2020)

COVID-19 Outcomes Among Participants in the NHLBI Myelodysplastic Syndromes (MDS) Natural History Study
por: Padron, Eric, et al.
Publicado: (2021)

Incidence and Burden of the Myelodysplastic Syndromes
por: Cogle, Christopher R.
Publicado: (2015)

Clinical Efficacy and Safety of Oral Decitabine/Cedazuridine in 133 Patients with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
por: Savona, Michael R., et al.
Publicado: (2020)

Oral Decitabine/Cedazuridine in Patients with Lower Risk Myelodysplastic Syndrome: A Longer-Term Follow-up of from the Ascertain Study
por: Garcia-Manero, Guillermo, et al.
Publicado: (2021)

Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes
por: Drusbosky, Leylah M., et al.
Publicado: (2017)

Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing?
por: Bejar, Rafael
Publicado: (2015)

High-risk MDS after HMAs
por: Adès, Lionel
Publicado: (2019)

The impact of spliceosome mutations in MDS
por: Boultwood, Jacqueline, et al.
Publicado: (2019)

The role of innate immunity in MDS pathogenesis
por: Sallman, David A., et al.
Publicado: (2019)

Flow cytometry as a fast, cost-effective tool to assess IGHV mutational status in CLL
por: Couillez, Guillaume, et al.
Publicado: (2022)

Efficacy of Oral Decitabine/Cedazuridine (ASTX727) in the CMML Subgroup from the Ascertain Phase 3 Study
por: Savona, Michael R., et al.
Publicado: (2021)

Evaluation of multiparametric flow cytometry in diagnosis & prognosis of myelodysplastic syndrome in India
por: Dhingra, Gaurav, et al.
Publicado: (2020)

Utility of assessing CD3 (+) cell chimerism within the first months after allogeneic hematopoietic stem‐cell transplantation for acute myeloid leukemia
por: Bendjelloul, Mehdi, et al.
Publicado: (2022)

Hereditary Predisposition to Acute Myeloid Leukemia in Older Adults
por: Fenwarth, Laurène, et al.
Publicado: (2021)

PB1769: STIM2, A CALCIUM CENSOR POTENTIALLY INVOLVED IN THE PATHOPHYSIOLOGY OF ACUTE MYELOID LEUKEMIA
por: Djordjevic, Stefan, et al.
Publicado: (2023)

HDAC6 regulates human erythroid differentiation through modulation of JAK2 signalling
por: Vong, Pascal, et al.
Publicado: (2022)

Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors
por: Reis-Alves, Suiellen C, et al.
Publicado: (2015)

P1404: HDAC6 REGULATES HUMAN ERYTHROID DIFFERENTIATION THROUGH MODULATION OF JAK2 SIGNALING
por: Vong, P., et al.
Publicado: (2022)

PIEZO1 activation delays erythroid differentiation of normal and hereditary xerocytosis-derived human progenitor cells
por: Caulier, Alexis, et al.
Publicado: (2020)

Flow Cytometry in the Diagnosis of Myelodysplastic Syndromes
por: Kárai, Bettina, et al.
Publicado: (2013)

Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome
por: Seror, Raphaele, et al.
Publicado: (2022)

De novo, heterozygous, loss‐of‐function mutations in SYNGAP1 cause a syndromic form of intellectual disability
por: Parker, Michael J., et al.
Publicado: (2015)

Salivary gland ultrasound abnormalities in primary Sjögren’s syndrome: consensual US-SG core items definition and reliability
por: Jousse-Joulin, Sandrine, et al.
Publicado: (2017)

Mapping Cell Phenomics with Multiparametric Flow Cytometry Assays
por: Liu, Yang, et al.
Publicado: (2022)

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes
por: Aanei, Carmen Mariana, et al.
Publicado: (2016)

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes
por: Della Porta, Matteo G., et al.
Publicado: (2017)

Reticulocytosis As a Whistleblower: A Rare Case of Acquired Elliptocytosis in a Myelodysplastic Syndrome Patient With Trisomy 8
por: Hage-Sleiman, Mehdi, et al.
Publicado: (2021)

Cyclone: an accessible pipeline to analyze, evaluate, and optimize multiparametric cytometry data
por: Patel, Ravi K., et al.
Publicado: (2023)

Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort
por: Bot, M., et al.
Publicado: (2010)

Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome
por: Jie, Kim E, et al.
Publicado: (2010)

Syndrome in Question()
por: Orasmo, Cínthia Rosane, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dt313hkfduj14g798eu91kuc4q